{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:16:28Z","timestamp":1794366988740,"version":"4.9.0"},"publisher-location":"Totowa, NJ","reference-count":47,"publisher":"Humana Press","isbn-type":[{"value":"9781607614531","type":"print"},{"value":"9781607614548","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010]]},"DOI":"10.1007\/978-1-60761-454-8_4","type":"book-chapter","created":{"date-parts":[[2009,10,30]],"date-time":"2009-10-30T14:18:55Z","timestamp":1256912335000},"page":"51-65","source":"Crossref","is-referenced-by-count":17,"title":["Human Gangliosides and Bacterial Lipo-oligosaccharides in the Development of Autoimmune Neuropathies"],"prefix":"10.1007","author":[{"given":"Nobuhiro","family":"Yuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,10,31]]},"reference":[{"key":"4_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/ana.410400414","volume":"40","author":"C. Hafer-Macko","year":"1996","unstructured":"Hafer-Macko, C., Hsieh, S.-T., Li, C. Y., Ho, T. W., Sheikh, K., Cornblath, D. R., McKhann, G. M., Asbury, A. K., and Griffin, J. W. (1996) Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann. Neurol.\n                40, 635\u2013644.","journal-title":"Ann. Neurol."},{"key":"4_CR2","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/ana.410390512","volume":"39","author":"C. E. Hafer-Macko","year":"1996","unstructured":"Hafer-Macko, C. E., Sheikh, K. A., Li, C. Y., Ho, T. W., Cornblath, D. R., McKhann, G. M., Asbury, A. K., and Griffin, J. W. (1996) Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann. Neurol.\n                39, 625\u2013635.","journal-title":"Ann. Neurol."},{"key":"4_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.it.2003.12.004","volume":"25","author":"C. W. Ang","year":"2004","unstructured":"Ang, C. W., Jacobs, B. C., and Laman, J. D. (2004) The Guillain-Barr\u00e9 syndrome: a true case of molecular mimicry. Trends Immunol.\n                25, 61\u201366.","journal-title":"Trends Immunol."},{"key":"4_CR4","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","volume":"51","author":"B. C. Jacobs","year":"1998","unstructured":"Jacobs, B. C., Rothbarth, P. H., van der Mech\u00e9, F. G. A., Herbrink, P., Schmitz, P. I. M., de Klerk, M. A., and van Doorn, P. A. (1998) The spectrum of antecedent infections in Guillain-Barr\u00e9 syndrome: a case-control study. Neurology\n                51, 1110\u20131115.","journal-title":"Neurology"},{"key":"4_CR5","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1056\/NEJM199511233332102","volume":"333","author":"J. H. Rees","year":"1995","unstructured":"Rees, J. H., Soudain, S. E., Gregson, N. A., and Hughes, R. A. C. (1995) Campylobacter jejuni infection and Guillain-Barr\u00e9 syndrome. N Engl. J. Med.\n                333, 1374\u20131379.","journal-title":"N Engl. J. Med."},{"key":"4_CR6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/01.WNL.0000133205.05169.04","volume":"63","author":"S. Kuwabara","year":"2004","unstructured":"Kuwabara, S., Ogawara, K., Misawa, S., Koga, M., Mori, M., Hiraga, A., Kanesaka, T., Hattori, T., and Yuki, N. (2004) Does Campylobacter jejuni infection elicit \u201cdemyelinating\" Guillain-Barr\u00e9 syndrome? Neurology\n                63, 529\u2013533.","journal-title":"Neurology"},{"key":"4_CR7","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1212\/WNL.40.12.1900","volume":"40","author":"N. Yuki","year":"1990","unstructured":"Yuki, N., Yoshino, H., Sato, S., and Miyatake, T. (1990) Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology\n                40, 1900\u20131902.","journal-title":"Neurology"},{"key":"4_CR8","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6","volume":"45","author":"T. W. Ho","year":"1999","unstructured":"Ho, T. W., Willison, H. J., Nachamkin, I., Li, C. Y., Veitch, J., Ung, H., Wang, G. R., Liu, R. C., Cornblath, D. R., Asbury, A. K., Griffin, J. W., and McKhann, G. M. (1999) Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barr\u00e9 syndrome. Ann. Neurol.\n                45, 168\u2013173.","journal-title":"Ann. Neurol."},{"key":"4_CR9","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/0140-6736(91)91767-O","volume":"337","author":"N. Yuki","year":"1991","unstructured":"Yuki, N., Sato, S., Miyatake, T., Sugiyama, K., Katagiri, T., and Sasaki, H. (1991) Motoneuron-disease-like disorder after ganglioside therapy. Lancet\n                337, 1109\u20131110.","journal-title":"Lancet"},{"key":"4_CR10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/ana.410380214","volume":"38","author":"I. Illa","year":"1995","unstructured":"Illa, I., Ortiz, N., Gallard, E., Juarez, C., Grau, J. M., and Dalakas, M. C. (1995) Acute axonal Guillain-Barr\u00e9 syndrome with IgG antibodies against motor axons following parenteral gangliosides. Ann. Neurol.\n                38, 218\u2013224.","journal-title":"Ann. Neurol."},{"key":"4_CR11","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1084\/jem.178.5.1771","volume":"178","author":"N. Yuki","year":"1993","unstructured":"Yuki, N., Taki, T., Inagaki, F., Kasama, T., Takahashi, M., Saito, K., Handa, S., and Miyatake, T. (1993) A bacterium lipopolysaccharide that elicits Guillain-Barr\u00e9 syndrome has a GM1 ganglioside-like structure. J. Exp. Med.\n                178, 1771\u20131775.","journal-title":"J. Exp. Med."},{"key":"4_CR12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4049\/jimmunol.180.1.39","volume":"180","author":"Y. Matsumoto","year":"2008","unstructured":"Matsumoto, Y., Yuki, N., van Kaer, L., Furukawa, K., Hirata, K., and Sugita, M. (2008) Guillain-Barr\u00e9 syndrome-associated IgG responses to gangliosides are generated independently of CD1 function in mice. J. Immunol.\n                180, 39\u201343.","journal-title":"J. Immunol."},{"key":"4_CR13","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1086\/499969","volume":"193","author":"M. Koga","year":"2006","unstructured":"Koga, M., Gilbert, M., Takahashi, M., Li, J., Koike, S., Hirata, K., and Yuki, N. (2006) Comprehensive analysis of bacterial risk factors for the development of Guillain-Barr\u00e9 syndrome after Campylobacter jejuni enteritis. J. Infect. Dis.\n                193, 547\u2013555.","journal-title":"J. Infect. Dis."},{"key":"4_CR14","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/ana.1012","volume":"49","author":"N. Yuki","year":"2001","unstructured":"Yuki, N., Yamada, M., Koga, M., Odaka, M., Susuki, K., Tagawa, Y., Ueda, S., Kasama, T., Ohnishi, A., Hayashi, S., Takahashi, H., Kamijo, M., and Hirata, K. (2001) Animal model of axonal Guillain-Barr\u00e9 syndrome induced by sensitization with GM1 ganglioside. Ann. Neurol.\n                49, 712\u2013720.","journal-title":"Ann. Neurol."},{"key":"4_CR15","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/jnr.21004","volume":"84","author":"R. Com\u00edn","year":"2006","unstructured":"Com\u00edn, R., Yuki, N., Lopez, P. H., and Nores, G. A. (2006) High affinity of anti-GM1 antibodies is associated with disease onset in experimental neuropathy. J. Neurosci. Res.\n                84, 1085\u20131090.","journal-title":"J. Neurosci. Res."},{"key":"4_CR16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/ana.33333","volume":"54","author":"K. Susuki","year":"2003","unstructured":"Susuki, K., Nishimoto, Y., Yamada, M., Baba, M., Ueda, S., Hirata, K., and Yuki, N. (2003) Acute motor axonal neuropathy rabbit model: immune attack on nerve root axons. Ann. Neurol.\n                54, 383\u2013388.","journal-title":"Ann. Neurol."},{"key":"4_CR17","doi-asserted-by":"publisher","first-page":"11404","DOI":"10.1073\/pnas.0402391101","volume":"101","author":"N. Yuki","year":"2004","unstructured":"Yuki, N., Susuki, K., Koga, M., Nishimoto, Y., Odaka, M., Hirata, K., Taguchi, K., Miyatake, T., Furukawa, K., Kobata, T., and Yamada, M. (2004) Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barr\u00e9 syndrome. Proc. Natl. Acad. Sci. U. S. A.\n                101, 11404\u201311409.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"4_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0165-5728(95)00052-4","volume":"60","author":"N. Yuki","year":"1995","unstructured":"Yuki, N., Ichihashi, Y., and Taki, T. (1995) Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain-Barr\u00e9 syndrome. J. Neuroimmunol.\n                60, 161\u2013164.","journal-title":"J. Neuroimmunol."},{"key":"4_CR19","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/glia.20503","volume":"55","author":"K. Susuki","year":"2007","unstructured":"Susuki, K., Baba, H., Tohyama, K., Kanai, K., Kuwabara, S., Hirata, K., Furukawa, K., Furukawa, K., Rasband, M. N., and Yuki, N. (2007) Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers. Glia\n                55, 746\u2013757.","journal-title":"Glia"},{"key":"4_CR20","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/brain\/120.12.2159","volume":"120","author":"N. Hirota","year":"1997","unstructured":"Hirota, N., Kaji, R., Bostock, H., Shindo, K., Kawasaki, T., Mizutani, K., Oka, N., Kohara, N., Saida, T., and Kimura, J. (1997) The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons. Brain\n                120, 2159\u20132169.","journal-title":"Brain"},{"key":"4_CR21","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/ana.410370405","volume":"37","author":"T. Takigawa","year":"1995","unstructured":"Takigawa, T., Yasuda, H., Kikkawa, R., Shigeta, Y., Saida, T., and Kitasato, H. (1995) Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers. Ann. Neurol.\n                37, 436\u2013442.","journal-title":"Ann. Neurol."},{"key":"4_CR22","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1523\/JNEUROSCI.4401-06.2007","volume":"27","author":"K. Susuki","year":"2007","unstructured":"Susuki, K., Rasband, M. N., Tohyama, K., Koibuchi, K., Okamoto, S., Funakoshi, K., Hirata, K., Baba, H., and Yuki, N. (2007) Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J. Neurosci.\n                27, 3956\u20133967.","journal-title":"J. Neurosci."},{"key":"4_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/ana.410370403","volume":"37","author":"S. G. Waxman","year":"1995","unstructured":"Waxman, S. G. (1995) Sodium channel blockade by antibodies: a new mechanism of neurological disease? Ann. Neurol.\n                37, 421\u2013423.","journal-title":"Ann. Neurol."},{"key":"4_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/ana.20546","volume":"58","author":"S. K. Halstead","year":"2005","unstructured":"Halstead, S. K., Humphreys, P. D., Goodfellow, J. A., Wagner, E. R., Smith, R. A., and Willison, H. J. (2005) Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome. Ann. Neurol.\n                58, 203\u2013210.","journal-title":"Ann. Neurol."},{"key":"4_CR25","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/brain\/awm316","volume":"131","author":"S. K. Halstead","year":"2008","unstructured":"Halstead, S. K., Zitman, F. M., Humphreys, P. D., Greenshields, K., Verschuuren, J. J., Jacobs, B. C., Rother, R. P., Plomp, J. J., and Willison, H. J. (2008) Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model. Brain\n                131, 1197\u20131208.","journal-title":"Brain"},{"key":"4_CR26","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0005-2744(81)90023-1","volume":"661","author":"S. Fujii","year":"1981","unstructured":"Fujii, S., and Hitomi, Y. (1981) New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin. Biochim. Biophys. Acta\n                661, 342\u2013345.","journal-title":"Biochim. Biophys. Acta"},{"key":"4_CR27","first-page":"393","volume":"35","author":"Y. Fujita","year":"1993","unstructured":"Fujita, Y., Inoue, I., Inagi, R., Miyata, T., Shinzato, T., Sugiyama, S., Miyama, A., and Maeda, K. (1993) Inhibitory effect of FUT-175 on complement activation and its application for glomerulonephritis with hypocomplementemia. Nippon Jinzo Gakkai Shi\n                35, 393\u2013397.","journal-title":"Nippon Jinzo Gakkai Shi"},{"key":"4_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0165-2478(91)90243-4","volume":"27","author":"R. Inagi","year":"1991","unstructured":"Inagi, R., Miyata, T., Maeda, K., Sugiyama, S., Miyama, A., and Nakashima, I. (1991) FUT-175 as a potent inhibitor of C5\/C3 convertase activity for production of C5a and C3a. Immunol. Lett.\n                27, 49\u201352.","journal-title":"Immunol. Lett."},{"key":"4_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jneuroim.2008.09.016","volume":"205","author":"V. Phongsisay","year":"2008","unstructured":"Phongsisay, V., Susuki, K., Matsuno, K., Yamahashi, T., Okamoto, S., Funakoshi, K., Hirata, K., Shinoda, M., and Yuki, N. (2008) Complement inhibitor prevents disruption of sodium channel clusters in a rabbit model of Guillain-Barr\u00e9 syndrome. J. Neuroimmunol.\n                205, 101\u2013104.","journal-title":"J. Neuroimmunol."},{"key":"4_CR30","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1074\/jbc.275.6.3896","volume":"275","author":"M. Gilbert","year":"2000","unstructured":"Gilbert, M., Brisson, J. R., Karwaski, M. F., Michniewicz, J., Cunningham, A. M., Wu, Y., Young, N. M., and Wakarchuk, W. W. (2000) Biosynthesis of ganglioside mimics in Campylobacter jejuni OH4384: identification of the glycosyltransferase genes, enzymatic synthesis of model compounds, and characterization of nanomole amounts by 600-MHz 1H and 13C NMR analysis. J. Biol. Chem.\n                275, 3896\u20133906.","journal-title":"J. Biol. Chem."},{"key":"4_CR31","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/89831","volume":"7","author":"A. Belkum van","year":"2001","unstructured":"van Belkum, A., van den Braak, N., Godschalk, P. C. R., Ang, W., Jacobs, B. C., Gilbert, M., Wakarchuk, W. W., Verbrugh, H., and Endtz, H. P. (2001) A Campylobacter jejuni gene associated with immune-mediated neuropathy. Nat. Med.\n                7, 752\u2013753.","journal-title":"Nat. Med."},{"key":"4_CR32","doi-asserted-by":"publisher","first-page":"5299","DOI":"10.1128\/IAI.70.9.5299-5303.2002","volume":"70","author":"I. Nachamkin","year":"2002","unstructured":"Nachamkin, I., Liu, J., Li, M., Ung, H., Moran, A. P., Prendergast, M. M., and Sheikh, K. (2002) Campylobacter jejuni from patients with Guillain-Barr\u00e9 syndrome preferentially expresses a GD1a-like epitope. Infect. Immun.\n                70, 5299\u20135303.","journal-title":"Infect. Immun."},{"key":"4_CR33","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/35001088","volume":"403","author":"J. Parkhill","year":"2000","unstructured":"Parkhill, J., Wren, B. W., Mungall, K., Ketley, J. M., Churcher, C., Basham, D., Chillingworth, T., Davies, R. M., Feltwell, T., Holroyd, S., Jagels, K., Karlyshev, A. V., Moule, S., Pallen, M. J., Penn, C. W., Quail, M. A., Rajandream, M. A., Rutherford, K. M., van Vliet, A. H., Whitehead, S., and Barrell, B. G. (2000) The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature\n                403, 665\u2013668.","journal-title":"Nature"},{"key":"4_CR34","first-page":"219","volume-title":"Campylobacter: Molecular and Cellular Biology","author":"M. Gilbert","year":"2005","unstructured":"Gilbert, M., Godschalk, P. C. R., Parker, C. T., Endtz, H. P., and Wakarchuk, W. W. (2005) Genetic bases for the variation in the lipooligosaccharide outer core of Campylobacter jejuni and possible association of glycosyltransferase genes with postinfectious neuropathies. In: Ketley J, Konkel M, editors. Campylobacter: Molecular and Cellular Biology. Norwich, UK: Horizon Scientific Press; pp. 219\u2013248."},{"key":"4_CR35","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1128\/JCM.43.6.2771-2781.2005","volume":"43","author":"C. T. Parker","year":"2005","unstructured":"Parker, C. T., Horn, S. T., Gilbert, M., Miller, W. G., Woodward, D. L., and Mandrell, R. E. (2005) Comparison of Campylobacter jejuni lipooligosaccharide biosynthesis loci from a variety of sources. J. Clin. Microbiol.\n                43, 2771\u20132781.","journal-title":"J. Clin. Microbiol."},{"key":"4_CR36","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1172\/JCI200415707","volume":"114","author":"P. C. R. Godschalk","year":"2004","unstructured":"Godschalk, P. C. R., Heikema, A. P., Gilbert, M., Komagamine, T., Ang, C. W., Glerum, J., Brochu, D., Li, J., Yuki, N., Jacobs, B. C., van Belkum, A., and Endtz, H. P. (2004) The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barr\u00e9 syndrome. J. Clin. Invest.\n                114, 1659\u20131665.","journal-title":"J. Clin. Invest."},{"key":"4_CR37","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1212\/WNL.43.10.1911","volume":"43","author":"A. Chiba","year":"1993","unstructured":"Chiba, A., Kusunoki, S., Obata, H., Machinami, R., and Kanazawa, I. (1993) Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barr\u00e9 syndrome: clinical and immunohistochemical studies. Neurology\n                43, 1911\u20131917.","journal-title":"Neurology"},{"key":"4_CR38","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/ana.410310619","volume":"31","author":"A. Chiba","year":"1992","unstructured":"Chiba, A., Kusunoki, S., Shimizu, T., and Kanazawa, I. (1992) Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann. Neurol.\n                31, 677\u2013679.","journal-title":"Ann. Neurol."},{"key":"4_CR39","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1212\/01.WNL.0000160399.08456.7C","volume":"64","author":"M. Koga","year":"2005","unstructured":"Koga, M., Gilbert, M., Li, J., Koike, S., Takahashi, M., Furukawa, K., Hirata, K., and Yuki, N. (2005) Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology\n                64, 1605\u20131611.","journal-title":"Neurology"},{"key":"4_CR40","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1212\/01.wnl.0000244468.22377.6b","volume":"67","author":"K. Kimoto","year":"2006","unstructured":"Kimoto, K., Koga, M., Odaka, M., Hirata, K., Takahashi, M., Li, J., Gilbert, M., and Yuki, N. (2006) Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies. Neurology\n                67, 1837\u20131843.","journal-title":"Neurology"},{"key":"4_CR41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0008-6215(97)00259-0","volume":"305","author":"J. E. Nam Shin","year":"1997","unstructured":"Nam Shin, J. E., Ackloo, S., Mainkar, A. S., Monteiro, M. A., Pang, H., Penner, J. L., and Aspinall, G. O. (1997) Lipo-oligosaccharides of Campylobacter jejuni serotype O:10: structures of core oligosaccharide regions from a bacterial isolate from a patient with the Miller-Fisher [sic] syndrome and from the serotype reference strain. Carbohydr. Res.\n                305, 223\u2013232.","journal-title":"Carbohydr. Res."},{"key":"4_CR42","doi-asserted-by":"publisher","first-page":"8164","DOI":"10.1021\/bi700685s","volume":"46","author":"R. S. Houliston","year":"2007","unstructured":"Houliston, R. S., Koga, M., Li, J., Jarrell, H. C., Richards, J. C., Vitiazeva, V., Schweda, E. K., Yuki, N., and Gilbert, M. (2007) A Haemophilus influenzae strain associated with Fisher syndrome expresses a novel disialylated ganglioside mimic. Biochemistry\n                46, 8164\u20138171.","journal-title":"Biochemistry"},{"key":"4_CR43","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1212\/01.wnl.0000176914.70893.14","volume":"65","author":"M. Koga","year":"2005","unstructured":"Koga, M., Takahashi, M., Masuda, M., Hirata, K., and Yuki, N. (2005) Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barr\u00e9 syndrome. Neurology\n                65, 1376\u20131381.","journal-title":"Neurology"},{"key":"4_CR44","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1074\/jbc.M108452200","volume":"277","author":"M. Gilbert","year":"2002","unstructured":"Gilbert, M., Karwaski, M. F., Bernatchez, S., Young, N. M., Taboada, E., Michniewicz, J., Cunningham, A. M., and Wakarchuk, W. W. (2002) The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni: biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J. Biol. Chem.\n                277, 327\u2013337.","journal-title":"J. Biol. Chem."},{"key":"4_CR45","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/mus.20762","volume":"35","author":"N. Yuki","year":"2007","unstructured":"Yuki, N. (2007) Ganglioside mimicry and peripheral nerve disease. Muscle Nerve.\n                35, 691\u2013711.","journal-title":"Muscle Nerve."},{"key":"4_CR46","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1093\/brain\/awf258","volume":"125","author":"Y. Gong","year":"2002","unstructured":"Gong, Y., Tagawa, Y., Lunn, M. P., Laroy, W., Heffer-Lauc, M., Li, C. Y., Griffin, J. W., Schnaar, R. L., and Sheikh, K. A. (2002) Localization of major gangliosides in the PNS: implications for immune neuropathies. Brain\n                125, 2491\u20132506.","journal-title":"Brain"},{"key":"4_CR47","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/(SICI)1097-4598(199908)22:8<1071::AID-MUS10>3.0.CO;2-0","volume":"22","author":"S. Kusunoki","year":"1999","unstructured":"Kusunoki, S., Chiba, A., and Kanazawa, I. (1999) Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia. Muscle Nerve.\n                22, 1071\u20131074.","journal-title":"Muscle Nerve."}],"container-title":["Methods in Molecular Biology","Functional Glycomics"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-60761-454-8_4.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T18:09:41Z","timestamp":1619892581000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-60761-454-8_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,31]]},"ISBN":["9781607614531","9781607614548"],"references-count":47,"URL":"https:\/\/doi.org\/10.1007\/978-1-60761-454-8_4","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-60761-454-8","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,31]]}}}